The number of U.S. women diagnosed with breast cancer could rise by as much as fifty percent over the next fifteen years.
New research suggests the increasing costs of treating breast cancer are linked to higher survival rates.
A new study shows one-third of breast cancer patients worry about the genetic risks of the disease but many never follow up with their doctor.
The United States spends four billion dollars a year on unnecessary medical costs due to mammograms that generate a false positive and on breast tumors that are unlikely to cause problems.
Women who learn to manage stress early in their breast cancer treatment may improve their mood and quality of life in years to come.
Text messages can help people show up to their doctor appointments.
Dillard's at Westgate Mall is helping women find out their bra sizes through 8:30 p.m. tonight.
A combination of three breast cancer drugs could prolong the life of some women by more than one year.
Ibrance, which is manufactured by Pfizer, is an experimental treatment for advanced breast cancer.
Triple negative breast cancer accounts for 15 to 20-percent of all breast cancers and strikes younger women more than other forms of the disease.